Amneal Pharmaceuticals (AMRX) Net Margin (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Net Margin of 10.8% for Q1 2026, up 726.0% year-over-year from 1.31% in Q1 2025, and up 77.34% quarter-over-quarter from 6.09% in Q4 2025.
Amneal Pharmaceuticals (AMRX) Net Margin (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Net Margin history runs 9 years deep, the most recent figure standing at 10.8% for Q1 2026.
- In Q1 2026, Net Margin rose 726.0% year-over-year to 10.8%; the TTM figure through Mar 2026 stood at 5.95% (up 481.0% YoY), while the FY2025 annual figure was 4.24%, up 842.0% from the prior year.
- Net Margin for Q1 2026 stood at 10.8%, up from 6.09% in the prior quarter.
- The five-year high for Net Margin was 10.8% in Q1 2026, with the low at 21.6% in Q2 2022.
- The 5-year median for Net Margin is 1.56% (2023), against an average of 1.14%.
- The sharpest annual moves came in 2022 and 2023: Net Margin slumped 2431 bps in 2022, then jumped 2359 bps in 2023.
- Amneal Pharmaceuticals' Net Margin stood at 0.27% in 2022, then slumped by 5940 bps to 15.99% in 2023, then jumped by 82 bps to 2.84% in 2024, then soared by 314 bps to 6.09% in 2025, then surged by 77 bps to 10.8% in 2026.
- Business Quant data shows AMRX's Net Margin at 10.8% in Q1 2026, 6.09% in Q4 2025, and 2.31% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 8.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.74% |
| Mar 31, 2026 | 10.80% |
| Dec 31, 2025 | 6.09% |
| Sep 30, 2025 | 2.31% |
| Jun 30, 2025 | 4.92% |
| Mar 31, 2025 | 3.54% |
| Dec 31, 2024 | -2.84% |
| Sep 30, 2024 | 1.67% |
| Jun 30, 2024 | 2.39% |
| Mar 31, 2024 | -12.39% |
| Dec 31, 2023 | -15.99% |
| Sep 30, 2023 | 1.56% |
| Jun 30, 2023 | 1.99% |
| Mar 31, 2023 | -1.25% |
| Dec 31, 2022 | 0.27% |
| Sep 30, 2022 | -0.49% |
| Jun 30, 2022 | -21.60% |
| Mar 31, 2022 | -0.43% |
| Dec 31, 2021 | -1.19% |
| Sep 30, 2021 | -0.80% |